The Open Targets team at our 10 year anniversary celebration in October 2024
Open Targets is based on the stunning Wellcome Genome Campus, home to some of the world's foremost institutes and organisations in genomics and computational biology. We work in dynamic teams at the interface of academic and pharma industry science on a crucial problem, how to be more successful in making drugs. Working with us, you will be exposed to new technologies and a dynamic set of scientists dedicated to translational research.
Our posts are usually in either one of our academic partners, The Wellcome Sanger Institute or EMBL-EBI and have terms and conditions associated with the employer.
Important note: applications may be reviewed on an ongoing basis and the advertised post(s) may be filled before the stated deadline.
This post is based at the University of Exeter.
Join a project to study immune response in neurodegenerative disease, as part of a large-scale collaborative research project involving, among others, the University of Exeter, Open Targets, the Wellcome Sanger Institute, EMBL-EBI, and the University of Oxford. The project aims to optimise and utilise cellular model systems, gene editing, and single-cell transcriptomic and spatial approaches to better understand immune responses in neurodegeneration.